INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 424m ago
HOUSE PTR23m ago
SEC 13F23m ago
ROBINHOOD CHAIN23m ago
Public company

MGNXMACROGENICS INC

CIK 0001125345

EDGAR filingsOpen in network
Disclosed transactions15
Buys / sells0 / 1
Max Insider Score21
Connections4with evidence

MGNX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KE
Kuriakose EmilDirector
MGNXMACROGENICS INC
Grant or award
A—
44.0K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Kuriakose EmilDirector · Nov 3, 2026
  • ← Insider ofevidence
    Peters Jeffrey StuartSenior VP, GC, and Secretary · Aug 20, 2026
  • ← Insider ofevidence
    Smith Beth AnnVP, Controller & Treasurer · Dec 10, 2025
9
KE
Kuriakose EmilDirector
MGNXMACROGENICS INC
Grant or award
A
—
7,500 sh
Oct 30, 2026
Nov 3, 2026
traded Oct 30, 2026
+4d
SEC FORM 4

Evidence

20
PS
Peters Jeffrey StuartSenior VP, GC, and Secretary
MGNXMACROGENICS INC
Open-market sale · 10b5-1 plan
SELL$129K
31.1K sh
Aug 19, 2026Aug 20, 2026
traded Aug 19, 2026
+1dSEC FORM 4

Evidence

9
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Tax withholding
F$723
423 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC FORM 4

Evidence

9
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Option exercise
M—
1,095 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC FORM 4

Evidence

15
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Grant or award
A—
15.6K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

15
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Grant or award
A—
93.8K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

13
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Option exercise
M—
1,095 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC FORM 4

Evidence

21
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Option exercise
M—
2,617 sh
Feb 7, 2026Feb 10, 2026
traded Feb 7, 2026
+3dSEC FORM 4

Evidence

21
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Option exercise
M—
1,583 sh
Feb 8, 2026Feb 10, 2026
traded Feb 8, 2026
+2dSEC FORM 4

Evidence

17
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Option exercise
M—
2,617 sh
Feb 7, 2026Feb 10, 2026
traded Feb 7, 2026
+3dSEC FORM 4

Evidence

13
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Tax withholding
F$1,830
1,011 sh
Feb 7, 2026Feb 10, 2026
traded Feb 7, 2026
+3dSEC FORM 4

Evidence

13
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Option exercise
M—
1,583 sh
Feb 8, 2026Feb 10, 2026
traded Feb 8, 2026
+2dSEC FORM 4

Evidence

13
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Tax withholding
F$1,108
612 sh
Feb 8, 2026Feb 10, 2026
traded Feb 8, 2026
+2dSEC FORM 4

Evidence

9
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Grant or award
A—
25.0K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC FORM 4

Evidence